---
document_datetime: 2023-09-21 19:10:57
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/krystexxa-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: krystexxa-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.645061
conversion_datetime: 2025-12-23 06:02:53.951398
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Krystexxa

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                           | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary                                                                                                                                                          |
|----------------------|-------------------------------------------------------------------------------------------------|-------------------------------------|------------------------------------------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10046 /201507  | Periodic Safety Update EU Single assessment - PEGLOTICASE                                       | 14/01/2016 product                  | n/a                                            |                                  | PRAC Recommendation - maintenance                                                                                                                                |
| PSUSA/10046 /201501  | Periodic Safety Update EU Single assessment - PEGLOTICASE                                       | 24/09/2015                          | 19/11/2015                                     | SmPC                             | Please refer to Krystexxa PSUSA/00010046/201501 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation. |
| IAIN/0007            | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV | 24/02/2015                          | n/a                                            |                                  |                                                                                                                                                                  |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet).

The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

Medicinal product no longer authorised

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                                                                                                                                                            |               |                         |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|-------------------------|-----------------------------------|
| PSUSA/10046 /201407 | Periodic Safety Update EU Single assessment - PEGLOTICASE                                                                                                                                                                                                                                                                                                                                                                                                                                  | 12/02/2015    | n/a                     | PRAC Recommendation - maintenance |
| PSUV/0004           | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 09/10/2014    | n/a                     | PRAC Recommendation - maintenance |
| T/0005              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 11/08/2014    | 08/10/2014              | SmPC, and authorised              |
| PSUV/0003           | Periodic Safety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 06/02/2014    | n/a                     | PRAC Recommendation - maintenance |
| IAIN/0002/G         | This was an application for a group of variations. C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) in the safety database and/or major contractual arrangements for the fulfilment of PhV obligations, and/or change of the site undergoing PhV activities C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the PhV system product | 30/08/2013 no | Labelling PL n/a longer |                                   |

Medicinal product no longer authorised